Martin Dreyling News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Martin dreyling. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Martin Dreyling Today - Breaking & Trending Today

Adding Ibrutinib to Chemoimmunotherapy Induction Improves FFS in Younger MCL

The addition of ibrutinib to chemoimmunotherapy induction with ASCT improved rates of failure-free survival in younger patients with mantle cell lymphoma.
....

Martin Dreyling , University Hospital Munich , International Prognostic Index , Department Of Internal Medicine , Prognostic Index , Internal Medicine , Hospital Munich , Ann Arbor ,

Emerging Data Continue to Affect BTK Inhibitor Usage in Mantle Cell Lymphoma

Monica D. Mead, MD, discusses the evolving use of the BTK inhibitors in the treatment of patients with MCL, the factors for selecting between ibrutinib, zanubrutinib, and acalabrutinib, and unmet needs for patients with MCL ....

United States , Los Angeles , Martin Dreyling , Monicad Mead , University Of California , Jonsson Comprehensive Cancer Center , Science Summit , Hematologic Malignancy , Comprehensive Cancer Center , Btk Inhibitor , Bruin Trial , Mantle Cell Lymphoma ,

Experts Spar Over Role of Real-World Data as Replacement for Clinical Trials in Hematology

A friendly debate held at the European Hematology Association 2023 Congress focused on the potential for real-world data to improve the generalizability of clinical trial results but also acknowledged the limitations and current challenges with these data. ....

France General , Îe De France , Martin Dreyling , Philippe Rousselot , Carsten Niemann , Copenhagen University , European Hematology Association , European Medicines Agency , Ludwig Maximilian University , European Consortium , Reducing Bureaucracy , Clinical Trials , Real World Data , Clinical Trial ,

KITE TO PRESENT NEW CAR T-CELL THERAPY DATA ACROSS MULTIPLE INDICATIONS AND MANUFACTURING EXPERIENCE AT EBMT 2023

KITE TO PRESENT NEW CAR T-CELL THERAPY DATA ACROSS MULTIPLE INDICATIONS AND MANUFACTURING EXPERIENCE AT EBMT 2023  Stockley Park, UK – 19 April 2023 – Kite, a Gilead Company, will support eight data presentations, including updated findings in multiple indications across its portfolio of two CAR T-c. ....

France General , United Kingdom , Santa Monica , United States , Foster City , Bijal Shah , Kai Diong , Dominique Tonelli , Jason Westin , Edouard Forcade , Dick Sundh , Georg Hess , Lucie Oberic , Fred Locke , Martin Dreyling , Axicabtagene Ciloleucel , Javier Munoz , Brexucabtagene Autoleucel Brexu , Francesca Lorraine Wei Inng , Cressida Robson , Julio Chavez , Suresh Vunnum , Armin Ghobadi , Olalekan Oluwole , Bryan Cassaday , Alison Sehgal ,

Adding Ibrutinib to Induction and Maintenance Improves FFS in Mantle Cell Lymphoma

Adding ibrutinib to induction and maintenance after transplant improves failure-free survival in patients with mantle cell lymphoma. ....

Martin Dreyling , University Hospital Munich ,